芝加哥 - （商业资讯） - 3月。9，2009-在Pittcon 2009，Bruker Corporation（NASDAQ：BRKR）推出了许多新的科学和分析产品和解决方案。今天引入的新系统和解决方案致力于为自信的常规分析带来更多的生产率和特异性，并为高级研究应用程序开放新的视野。
布鲁克（Bruker）基于X射线分析，红外和NMR分子光谱以及质谱法宣布了几个新的面向溶液，转键，按钮分析仪。布鲁克（Bruker）利用其高性能技术进入新的，更紧凑，更易于使用，更快，更敏感，更具体的分析解决方案，这些解决方案涉及大型药品/生物技术，应用和工业市场。必威东盟体育应用范围从生物制剂质量控制（QC）到在线制药工艺分析技术（PAT）平板电脑表征，食品和饲料分析，再到取证，贵金属和水泥的元素分析，再到阳性材料识别（PMI）必威手机客户端电力和航空航天行业。
同时，布鲁克（Bruker）正在引入尖端，真正创新且完全独特的新研究功能，这将使科学家能够在膜蛋白研究和应用蛋白质组学中开放新的科学领域。
The new products and solutions launched by Bruker at Pittcon 2009 include:
X-Ray Materials Research and Elemental Analysis
- D2移相器™:力量进入本chtop X-ray diffraction (XRD) market with a compact, high-performance XRD spectrometer for the qualitative and quantitative analysis of crystalline phases.
- S8 Lion™：Bruker enters the simultaneous wavelength dispersive X-ray Fluorescence (WDXRF) market with a high-end, next-generation spectrometer for process and quality control in cement, minerals and mining.
- M1 ORA™和M4 TORNADO™：Bruker通过方便，小的贵金属和珠宝分析仪以及高端，自动化的，真空的微型XRF光谱仪，用于微型X射线荧光（µ-XRF）市场，扩展其产品组合，用于非损害，用于非损坏的高端，真空。在固体或液体样品，颗粒，夹杂物和涂料上，具有前所未有的速度和准确性的元素微分析，包括微电子，ROHS，取证和地质。
- S1 SORTER & S1 TURBOSD: Bruker broadens its handheld XRF product line with a fast, affordable alloy sorter, and a next-generation SDD-based high-performance handheld XRF for the most demanding applications and light-element analysis.
- Q8 MAGELLAN™:This new version of Bruker’s successful, high-end Q8 spark-OES series provides even better performance, long-term stability, convenience and ease-of-use for the most demanding metallurgical applications.
Molecular Spectroscopy
- 263 GHz Avance™固态DNP-NMR光谱仪：布鲁克先驱者是世界上第一个商业可用的固态DNP-NMR系统，该系统为生物固体和纳米材料（尤其是膜蛋白）领域的科学研究开辟了新的可能性。必威手机客户端DNP-NMR可以提供50倍或更高的信号增强因子。
- TANDEM™ and LANCIR™: Bruker expands its market leadership in pharmaceutical Process Analytical Technology (PAT) with next-generation near infrared (NIR) on-line PAT analyzers for blend uniformity and tablet characterization.
生命科学质谱法
- EdmassTM微: Bruker leverages its leadership in research proteomics into the new field of ‘applied proteomics’ with the introduction of its revolutionary, top-downEdmassprotein sequencing solution for all molecular biologists without mass spectrometry expertise, as well as for biologics QC in pharma, biotech and CRO companies. TheEdmass Micro溶液基于方便的台式MALDI-TOF质谱法，该质谱法将片段完整蛋白质跨质量范围完整，并调用多达80个残基的氨基酸序列，所有这些都没有先验的蛋白质消化。纯化或重组蛋白的序列确认仅需几分钟，而本质上不需要消耗品。
- Edmass™Ultra：这个高端Edmasssolution is based on high-performance MALDI-TOF/TOF technology and in addition delivers and applies Bruker’s uniqueT3-Sequencing™ technology to provide protein N- and C-terminal sequence information, even on N-term modified (blocked) proteins, thereby overcoming many of the previous limitations of now discontinued Edman sequencing technology.
Frank Laukien, Ph.D., Bruker’s President and CEO, commented: "We are very pleased to unveil so many innovative systems and solutions at Pittcon this year, and believe that our new products will further enhance our position in the market, offering exceptionally powerful and convenient capabilities to our customers. Particularly, our Bruker AXS Materials Research and Elemental Analysis businesses have introduced numerous new products that had been under development in some cases for several years, and which now leverage our industry-leading technology portfolio across a much broader range of applications than ever before. With our new product launches today, Bruker AXS has entered new market segments in simultaneous WDXRF and micro-XRF, significantly increasing our addressable markets.
Today, the Bruker BioSpin group is opening up a new page on solid-state NMR. The dramatic signal enhancement factors that can be achieved with our new and unique DNP-NMR system, enable researchers to study important membrane proteins or dilute samples that had previously been inaccessible to NMR. Bruker BioSpin today also announces its acquisition of PERCH Solutions Ltd., a Spectral Prediction and Molecular Modeling Software company whose products Bruker has integrated for small molecule structure verification and elucidation by NMR.”
Laukien博士继续说：“引入更快，更强大，更方便的下一代蛋白测序技术，使我们的新Edmasssolution an excellent example of the progress made in proteomics research to where today we really are at the dawn of a new ‘applied proteomics’ age with convenient, new proteomics-derived products for all biologists, clinical researchers, and in the future also for proteomics-based clinical routine applications and IVD.”
Bruker的完整新产品清单和详细的新闻稿现已可用www.fatactor.com/pittcon2009.
Pittcon®是匹兹堡分析化学和应用光谱会议的注册商标。
Photos/Multimedia Gallery Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5912580&lang=en
Source: Bruker Corporation
Bruker Corporation
投资者关系：
Stacey Desrochers, + 1-978-663-3660, ext. 1115
ir@bruker.com
或者
媒体：
Haydar Kustu， + 1-978-439-9899，Ext。5134
pr@bruker.com